Home › Juvenile Arthritis › New York
Pag-aaral pangklinika para sa Juvenile Arthritis sa New York
5 pag-aaral para sa Juvenile Arthritis ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Col Uni Med Center New York Presby, New York
Nagre-recruitPhase 1
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06751238Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Boston Childrens Health Physicians /ID# 253437, Valhalla
Nagre-recruitPhase 3
Edad 1 hanggang 17 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Columbia University Medical Center /ID# 262587, New York
- Boston Childrens Health Physicians /ID# 258061, Valhalla
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Albany Medical College, Albany
- Cohen Children's Medical Center of New York, Lake Success
- Hospital for Special Surgery, New York
- at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT02418442Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07138898Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.